176 related articles for article (PubMed ID: 37692950)
1. A pan-cancer analysis of pituitary tumor-transforming 3, pseudogene.
Li J; Shaikh SN; Uqaili AA; Nasir H; Zia R; Akram MA; Jawad FA; Sohail S; AbdelGawwad MR; Almutairi SM; Elshikh MS; Jamil M; Rasheed RA
Am J Transl Res; 2023; 15(8):5408-5424. PubMed ID: 37692950
[TBL] [Abstract][Full Text] [Related]
2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of the oncogenic role of FAM83D across cancers based on data mining.
Geng Y; Liu J; Wang Z; Liu T; Peng X; Huang Y
Cell Cycle; 2023 Apr; 22(8):1005-1019. PubMed ID: 36710419
[TBL] [Abstract][Full Text] [Related]
4. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
[TBL] [Abstract][Full Text] [Related]
5. Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.
Sial N; Saeed S; Ahmad M; Hameed Y; Rehman A; Abbas M; Asif R; Ahmed H; Hussain MS; Rehman JU; Atif M; Khan MR
Int J Gen Med; 2021; 14():7025-7042. PubMed ID: 34707394
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.
Sial N; Rehman JU; Saeed S; Ahmad M; Hameed Y; Atif M; Rehman A; Asif R; Ahmed H; Hussain MS; Khan MR; Ambreen A; Ambreen A
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908119
[TBL] [Abstract][Full Text] [Related]
7. The Oncogenic Roles of
Grzechowiak I; Graś J; Szymańska D; Biernacka M; Guglas K; Poter P; Mackiewicz A; Kolenda T
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32824814
[TBL] [Abstract][Full Text] [Related]
8. The Pseudogene PTTG3P Promotes Cell Migration and Invasion in Esophageal Squamous Cell Carcinoma.
Zhang Z; Shi Z
Open Med (Wars); 2019; 14():516-522. PubMed ID: 31346548
[TBL] [Abstract][Full Text] [Related]
9. A pan-cancer analysis of GINS complex subunit 4 to identify its potential role as a biomarker in multiple human cancers.
Usman M; Okla MK; Asif HM; AbdElgayed G; Muccee F; Ghazanfar S; Ahmad M; Iqbal MJ; Sahar AM; Khaliq G; Shoaib R; Zaheer H; Hameed Y
Am J Cancer Res; 2022; 12(3):986-1008. PubMed ID: 35411239
[TBL] [Abstract][Full Text] [Related]
10. Decoding SEC24 Homolog D, COPII coat complex component accuracy as a signature gene in three human cancers.
Du W; Sun Y; Ji W; Luo T; Zhang D; Guo W; Liang J; Lv Y; Dong M; Li K
Am J Cancer Res; 2023; 13(8):3686-3704. PubMed ID: 37693152
[TBL] [Abstract][Full Text] [Related]
11. High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.
Lou W; Ding B; Fan W
Mol Ther Oncolytics; 2019 Sep; 14():15-26. PubMed ID: 31011629
[TBL] [Abstract][Full Text] [Related]
12. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
Hu Y; Chen J; Liu M; Feng Q; Peng H
Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
[TBL] [Abstract][Full Text] [Related]
14. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
Front Genet; 2022; 13():895281. PubMed ID: 35754792
[No Abstract] [Full Text] [Related]
15. Identification of hub genes associated with head and neck squamous cell carcinoma by integrated bioinformatics approach and RNA-seq validation analysis.
Shabeer A; Mustafa S; Bukhari RS; Abdel-Maksoud MA; Almutairi SM; Al-Qahtani WH; Chandio K; Khan NY; Gul J; Aufy M
Am J Cancer Res; 2023; 13(4):1259-1277. PubMed ID: 37168331
[TBL] [Abstract][Full Text] [Related]
16. Screening of four signature genes for clinical testing through bioinformatics and in vitro methods in head and neck squamous cell carcinoma.
Javed M; Bukhari RS; Rasool R; Alhomrani M; Alghamdi SA; Habeeballah H; Ramzan F; Baothman BK; Kashif M; Almaghrabi S; Izmirly AM; Khalid SY
Am J Cancer Res; 2023; 13(5):1826-1844. PubMed ID: 37293145
[TBL] [Abstract][Full Text] [Related]
17. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
18. PTTG3P promotes gastric tumour cell proliferation and invasion and is an indicator of poor prognosis.
Weng W; Ni S; Wang Y; Xu M; Zhang Q; Yang Y; Wu Y; Xu Q; Qi P; Tan C; Huang D; Wei P; Huang Z; Ma Y; Zhang W; Sheng W; Du X
J Cell Mol Med; 2017 Dec; 21(12):3360-3371. PubMed ID: 28631396
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation.
Feng Y; Zhou YH; Zhao J; Su XL; Chen NX; Zhao YQ; Ye Q; Hu J; Ou-Yang ZY; Zhong MM; Yang YF; Han PJ; Guo Y; Feng YZ
Front Genet; 2023; 14():1041042. PubMed ID: 36936420
[No Abstract] [Full Text] [Related]
20. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
